Modified lipoproteins, cytokines and macrovascular disease in non-insulin-dependent diabetes mellitus.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Annals medicus

• Publication date

  1996-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3109/07853899608999092PMID 8862690
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LDL From Patients With Well-Controlled IDDM Is Not More Susceptible to In Vitro Oxidation

  1996cited by this paper
• Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells.

  1995cited by this paper
• Activation of human monocyte-derived macrophages by immune complexes containing low-density lipoprotein.

  1995cited by this paper
• Reduced Expression of Hexokinase II in Insulin-Resistant Diabetes

  1995cited by this paper
• Isolation, Characterization, and Metabolism of the Glycated and Nonglycated Subfractions of Low-Density Lipoproteins Isolated from Type I Diabetic Patients and Nondiabetic Subjects

  1995cited by this paper
• Oxidized Low-density Lipoprotein Decreases the Expression of Endothelial Nitric Oxide Synthase (*)

  1995cited by this paper
• Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits.

  1995cited by this paper
• Oxidisability of low density lipoproteins in patients with carotid or femoral artery atherosclerosis.

  1995cited by this paper
• Effects of oxidized LDL on mononuclear phagocytes: inhibition of induction of four inflammatory cytokine gene RNAs, release of NO, and cytolysis of tumor cells

  1995cited by this paper
• Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins.

  1994cited by this paper
• Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease.

  1994cited by this paper
• Reduced Plasma Peroxyl Radical Trapping Capacity and Increased Susceptibility of LDL to Oxidation In Poorly Controlled IDDM

  1994cited by this paper
• Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.

  1994cited by this paper
• Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.

  1994cited by this paper
• LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers.

  1994cited by this paper
• Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells.

  1994cited by this paper
• Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient?

  1993cited by this paper
• Lipid advanced glycosylation: pathway for lipid oxidation in vivo.

  1993cited by this paper
• Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells.

  1993cited by this paper
• Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease.

  1993cited by this paper
• Oxidized low-density lipoprotein enhances monocyte-endothelial cell binding against shear-stress-induced detachment.

  1993cited by this paper
• Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers

  1993cited by this paper
• Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium.

  1992cited by this paper
• Autoantibody against oxidised LDL and progression of carotid atherosclerosis.

  1992cited by this paper
• Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells.

  1992cited by this paper
• Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man.

  1992cited by this paper
• Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies.

  1991cited by this paper
• Oxidative modification of glycated low density lipoprotein in the presence of iron.

  1991cited by this paper
• Inhibition of lipopolysaccharide-induced interleukin-1 beta mRNA expression in mouse macrophages by oxidized low density lipoprotein.

  1991cited by this paper
• Erythrocyte-bound low-density lipoprotein immune complexes lead to cholesteryl ester accumulation in human monocyte-derived macrophages.

  1991cited by this paper
• Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC.

  1991cited by this paper
• The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages.

  1991cited by this paper
• Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein.

  1991cited by this paper
• Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

  1990cited by this paper
• Metabolism of very low- and low-density lipoproteins isolated from normolipidaemic Type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophages

  1990cited by this paper
• Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes.

  1990cited by this paper
• Lipoproteins in normal and atherosclerotic aorta.

  1990cited by this paper
• Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages.

  1990cited by this paper
• Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis.

  1990cited by this paper
• Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits.

  1990cited by this paper
• Autoxidative Glycosylation and Possible Involvement of Peroxides and Free Radicals in LDL Modification by Glucose

  1990cited by this paper
• Endothelial-leukocyte adhesion molecule-1-dependent and leukocyte (CD11/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium.

  1989cited by this paper
• A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein.

  1989cited by this paper
• Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA.

  1989cited by this paper
• Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.

  1989cited by this paper
• Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.

  1989cited by this paper
• Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages: different uptake mechanisms for acetylated and oxidized low density lipoproteins.

  1989cited by this paper
• Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

  1989cited by this paper
• IL-1 and IFN-gamma increase vascular permeability.

  1988cited by this paper
• Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation

  1988cited by this paper
• Enhancement of Platelet Aggregation by Low-Density Lipoproteins From IDDM Patients

  1988cited by this paper
• Accumulation of cholesteryl esters in macrophages incubated with human lipoprotein-antibody autoimmune complex.

  1988cited by this paper
• IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor.

  1988cited by this paper
• Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits.

  1988cited by this paper
• Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.

  1988cited by this paper
• Non-enzymatic glycosylation of low-density lipoprotein. Results of an affinity chromatography method

  1988cited by this paper
• Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.

  1988cited by this paper
• Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes.

  1988cited by this paper
• Glycosylation of Low-Density Lipoprotein Enhances Cholesteryl Ester Synthesis in Human Monocyte-Derived Macrophages

  1988cited by this paper
• Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor.

  1987cited by this paper
• Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells.

  1987cited by this paper
• Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation.

  1987cited by this paper
• Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from Type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins

  1987cited by this paper
• Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes.

  1987cited by this paper
• Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

  1986cited by this paper
• Glycosylation of low density lipoprotein in patients with Type I (insulin-dependent) diabetes: Correlations with other parameters of glycaemic control

  1986cited by this paper
• Nonenzymatic Glycosylation Products on Collagen Covalently Trap Low-Density Lipoprotein

  1985cited by this paper
• Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.

  1985cited by this paper
• Erythrocyte-bound immune complexes trigger the release of interleukin-1 from human monocytes.

  1985cited by this paper
• Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation.

  1985cited by this paper
• Glucosylation of Low-Density Lipoproteins to an Extent Comparable to That Seen in Diabetes Slows Their Catabolism

  1984cited by this paper
• Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells

  1984cited by this paper
• Nonenzymatic Glucosylation of Low-Density Lipoprotein Alters Its Biologic Activity

  1982cited by this paper
• Glycosylation of LDL decreases its ability to interact with high-affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo.

  1982cited by this paper
• Nonenzymatic Glycosylation of Low Density Lipoproteins In Vitro: Effects on Cell-interactive Properties

  1981cited by this paper
• Non‐enzymatic glycosylation of human serum lipoproteins Elevated ϵ‐lysine glycosylated low density lipoprotein in diabetic patients

  1981cited by this paper
• Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.

  1980cited by this paper

• Diabetic Complications and Oxidative Stress: A 20-Year Voyage Back in Time and Back to the Future

  2021cites this paper
• Outcomes after Lower Extremity Revascularization for Treatment of Critical Limb Ischemia with Tissue Loss in Patients with Chronic Immune-Mediated Inflammatory Disease.

  2019cites this paper
• Gender differential in apo E genotypes’ correlative tendency to dyslipidaemia responsiveness upon flaxseed oil administration in adult type 2 diabetic patients not meeting the 2008 Canadian Practice Guidelines

  2010cites this paper
• La aterosclerosis como desencadenante de la patología cardiovascular

  2010cites this paper
• Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.

  2009cites this paper
• No gender associated differences in LDL oxidation in response to a CuSO 4 challenge in a population of Caucasians with well-controlled type 2 diabetes

  2009cites this paper
• Data mart based research in heart surgery

  2008cites this paper
• The Macrophage at the Crossroads of Insulin Resistance and Atherosclerosis

  2007cites this paper
• Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques?

  2007cites this paper
• Mechanisms, Significance and Treatment of Vascular Dysfunction in Type 2 Diabetes Mellitus

  2005cites this paper
• Characterization of native and oxidized human low-density lipoproteins by the Z-scan technique.

  2004cites this paper
• Preoperative high leukocyte count: a novel risk factor for stroke after cardiac surgery.

  2003cites this paper
• The Role of Microscopy in Understanding Atherosclerotic Lysosomal Lipid Metabolism

  2003cites this paper
• Activation of human aortic endothelial cells by LDL from Type 1 diabetic patients: an in vitro study.

  2002cites this paper
• Is diabetic hypercoagulability an acquired annexinopathy? Glycation of annexin II as a putative mechanism for impaired fibrinolysis in diabetic patients.

  2002cites this paper
• Molecular mechanisms of diabetic cardiovascular disease.

  2002cites this paper
• Effect of inflammatory cytokines on the metabolism of low-density lipoproteins by human vascular endothelial cells.

  2001cites this paper
• Lipidstoffwechsel und Diabetes

  2001cites this paper
• [Processes of modification of lipoproteins. Physiological and pathogenetical role of modified lipoproteins].

  2000cites this paper
• APA hamster model for diabetic atherosclerosis. 2. Analysis of lipids and lipoproteins.

  2000cites this paper
• Endothelial adhesion molecule expression is enhanced in the aorta and internal mammary artery of diabetic patients.

  1999cites this paper
• Importance of glycation in the acceleration of low density lipoprotein (LDL) uptake into macrophages in patients with diabetes mellitus.

  1999cites this paper
• Leukocytosis in acute stroke: relation to initial stroke severity, infarct size, and outcome: the Copenhagen Stroke Study.

  1999cites this paper
• Effect of glycated low density lipoprotein on smooth muscle cell proliferation.

  1999cites this paper
• Increased Leucine Turnover and Insulin Resistance in Men with Advanced HIV Infection

  1999cites this paper
• Nonoxidative modifications of lipoproteins in atherogenesis.

  1999cites this paper
• Influence of low density lipoprotein from insulin-dependent diabetic patients on platelet functions.

  1999cites this paper
• Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis.

  1998cites this paper
• Specific and scavenger low-density lipoprotein receptors involved in the disturbed lipid metabolism of patients with non-insulin-dependent diabetes mellitus are independent of obesity.

  1998cites this paper
• Postprandial Lipoproteins in Non‐insulin‐dependent Diabetes Mellitus

  1997cites this paper